Latest Tag: Biosafety Resources
6 September 2024
La biotechnologie de la « boîte noire » – Intégration de l’intelligence artificielle à la biologie de synthèse
S’attaquer aux risques, au battage médiatique et aux inégalités qui sous-tendent la biologie générative Click here for the English version. Haga clic aquí para la versión en español. Le Centre africain pour la biodiversité (ACB), en collaboration avec le Réseau Tiers-monde (TWN) et l’ETC Group, a produit une note d’information opportune avant la 16e réunion […]
6 September 2024
La caja negra de la biotecnología – Integración de la inteligencia artificial con la biología sintética
Afrontar los riesgos, exageraciones y desigualdades de la biología generativa Click here for the English version. Cliquez ici pour la version française. El Centro Africano para la Biodiversidad (ACB), junto con la Third World Network (TWN) y el ETC Group, han elaborado un oportuno documento informativo de cara a la 16ª reunión de la Conferencia […]
3 September 2024
‘Black Box’ Biotechnology – Integration of artificial intelligence with synthetic biology
Addressing the risks, hype, and inequities underpinning generative biology Haga clic aquí para la versión en español. Cliquez ici pour la version française. The African Centre for Biodiversity (ACB), together with Third World Network (TWN) and ETC Group, have produced a timely briefing paper ahead of the 16th meeting of the Conference of the Parties […]
1 March 2023
ACB at the 2022 UN Biodiversity Conference (COP 15)
The 2022 UN Biodiversity Conference (COP 15) was held in Montreal, Canada, 7-19 December. Governments from around the world came together to work towards an agreement on a new set of goals to guide global action through 2030 to halt and reverse nature loss. The Kunming-Montreal Global Biodiversity Framework (GBF) was adopted during COP 15 […]
20 April 2020
COVID-19: Access to medicine & implications for Africa
ACB brings you a new discussion paper Passer à la version française Clique aqui para a versão portuguesa Dear Friends and Colleagues, Expeditious and affordable access to medicines and other healthcare items will be critical to reducing the toll of COVID-19 in Africa. But if nothing is done to compel corporations to make their patents […]
15 October 2012
Setting the record straight on the Seralini GM maize rat study: why the SA government must urgently intervene
In this briefing we respond to the main criticisms of the Seralini GM maize rat study (which have been appearing ad nauseum in the world’s mainstream media); provide some background as to the importance of the NK603 GM maize to the biotechnology industry (and hence the scale of their reaction); and place the attacks on […]